You are here: Industry Insights > RNA

News List

Skyhawk Therapeutics, Merck Expand RNA Alliance contractpharma
May 14, 2020
Aims to discover and develop novel small molecules that modulate RNA splicing for autoimmune and metabolic diseases.
New kind of CRISPR technology to target RNA, including RNA viruses like coronavirus worldpharmanews
March 17, 2020
CRISPR-based genetic screens have helped scientists identify genes that are key players in sickle-cell anemia, cancer immunotherapy, lung cancer metastasis, and many other diseases.
Skyhawk, Genentech Enter Exclusive Multi-target RNA Alliance contractpharma
July 17, 2019
Will leverage SkySTAR platform to discover and develop small molecule treatments for oncology and neurological disease targets.
Agendia Announces Publication of Study Validating Use of MammaPrint and BluePrint Molecular Diagnostics using Targeted RNA Next-Generation Sequencing Technology b3cnewswire
June 21, 2019
Agendia Announces Publication of Study Validating Use of MammaPrint and BluePrint Molecular Diagnostics using Targeted RNA Next-Generation Sequencing Technology.
RNA-based therapy cures lung cancer europeanpharmaceuticalreview
April 25, 2019
By turning down the activity of a specific RNA molecule, researchers have cured lung tumours in mice…
Saliva diagnostics: Will saliva translate into a real diagnostic tool? europeanpharmaceuticalreview
April 22, 2019
Saliva has been used to measure stress hormones, enzyme levels and cancer mutations…
Identifying mutations that give bacteria antibiotic resistance europeanpharmaceuticalreview
April 22, 2019
Ribosomal RNA is one of the main targets of antibiotics, however mutations in the rRNA form resistance against the drug and is a well known route…
A better CRISPR? RNA 'hairpins' could improve gene editing fiercebiotech
April 17, 2019
One of the biggest worries holding back the burgeoning field of CRISPR gene editing is that the technology can make mistakes, causing off-target effects by cutting the wrong piece of DNA.
Research from XJTLU advances RNA modification mapping biospectrumasia
March 25, 2019
Led by Dr Jia Meng from the Department of Biological Sciences, the research was recently published in Nucleic Acids Research.
Moderna shares slide after record $604m US listing pharmaphorum
December 11, 2018
RNA drug specialist Moderna smashed the record for an initial public offering (IPO) in the US on Friday, raising a whopping $604 million, although its shares retreated 19% after the debut......

Previous page 1 2 3 4 Next page